Welcome to our Hematology section

At Janssen we strive for excellence and, as a partner in hematology, we are committed to delivering high quality medical education whilst providing a platform for knowledge exchange and innovation. To help us achieve this we are privileged to have the support and participation of the internationally renowned experts who form our scientific committee and faculties. Their involvement ensures we continue to provide clinically relevant and balanced education.

ION AT EHA

Janssen Medical Education Academy

HME-Academy.com

The HME- Academy site is an excellent source for educational materials delivered by internationally respected experts who are leaders in their field. You will find the latest data and thinking on the management of patients across a range of hematological malignancies including Multiple Myeloma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Waldenströms Macroglobulinemia and Acute Myeloid Leukemia.

 

By clicking on  “SEE EXPERT OPINIONS” you will be redirected to the section on disease management and clinical practice opinion , here you will also find information of upcoming events.

 

See Expert opinions

HME-Forum.com

The HME-forum is an innovative programme developed with an eminent scientific committee where, through live interactive broadcasts, viewing clinicians can hear experts discuss latest data and its impact on clinical practice. During each roundtable broadcast you will have the opportunity to ask questions of the faculty which will be addressed live.
 
Once registered for an upcoming broadcast you may also choose to watch the webinar at a more convenient time along with other past broadcasts.

 

Visit website to register

B-Cell Malignancies 

B-cell malignancies represent a diverse collection of diseases, including most non-Hodgkin’s lymphomas (NHL), some leukaemias, and myelomas. Examples include chronic lymphocytic leukaemia, ...

 

Visit website

Our Partnerships

AML GLOBAL PORTAL (AGP)

Janssen has provided educational grants to the AML Global Portal (AGP, enabling the sharing of medical education on Acute Myeloid Leukemia (AML), for AML treating physicians as well as AML researchers....

Website

EBMT

The EBMT is a not-for-profit medical and scientific organisation established in 1974. It is dedicated to fighting life-threatening blood cancers and diseases and improving patients’ lives...

Website

ECANCER

Janssen has provided educational grants to support ecancer in their role to provide independent education to international oncologists and hematologists treating patients with solid tumors and hematological malignancies....

Website

EHA LEARNING CENTER

The European Hematology Association (EHA) is a non-profit scientific association that represents European medical professionals with an active interest in hematology. EHA was founded in June 1992 and currently has around 4000 members....

Website

EPG HEALTH MEDIA

EPG Health Media publishes www.epgonline.org, the website for healthcare professionals (HCPs). Since 2000, epgonline.org has provided doctors in Europe and worldwide with access to disease and treatment information online...

Website

HAEMATOLOGY NURSES AND HEALTHCARE PROFESSIONALS GROUP

The Haematology Nurses and Healthcare Professionals Group has been established to support nurses and other health care professionals through the rapidly evolving landscape of haematology and enable them to deliver optimal care to patients and support their families....

Website

INTERNATIONAL MYELOMA FOUNDATION

Founded in 1990, the International Myeloma Foundation (IMF) is the oldest and largest myeloma-specific charity in the world. With more than 350,000 members in 140 countries, the IMF serves myeloma patients, family members, and the medical community...

Website

LYMPHOMA HUB

The Lymphoma Hub is a global physician education platform and social network, dedicated to serving as a trusted online resource and knowledge exchange platform to improve awareness and understanding of lymphomas and CLL...

Website

 

ITEM CODE: PHEM/HEM/0717/0003(1) | DATE OF PREPARATION: FEBRUARY 2018